U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H7ClN6O2
Molecular Weight 242.622
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MITOZOLOMIDE

SMILES

NC(=O)C1=C2N=NN(CCCl)C(=O)N2C=N1

InChI

InChIKey=QXYYYPFGTSJXNS-UHFFFAOYSA-N
InChI=1S/C7H7ClN6O2/c8-1-2-14-7(16)13-3-10-4(5(9)15)6(13)11-12-14/h3H,1-2H2,(H2,9,15)

HIDE SMILES / InChI

Molecular Formula C7H7ClN6O2
Molecular Weight 242.622
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Mitozolomide is an antineoplastic agent patented by May and Baker Ltd for cancer treatment. Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression.

Originator

Approval Year

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
100 mg/m^2 every 6 weeks.
Route of Administration: Intravenous
Substance Class Chemical
Record UNII
E3U7286V3W
Record Status Validated (UNII)
Record Version